This document presents a case study of a 35-year-old male patient with recurrent hemoptysis. Testing revealed pulmonary arteriovenous malformations (PAVMs). PAVMs are abnormal connections between pulmonary arteries and veins, bypassing the capillary bed and causing a right-to-left shunt. The patient's PAVMs were likely hereditary as 90% of PAVMs occur in patients with Hereditary Hemorrhagic Telangiectasia. Percutaneous embolization is usually performed to occlude the PAVM connections and reduce the risk of complications from paradoxical embolism. Long term follow up is important after embolization to monitor for potential recanalization of treated
This presentation is about pulmonary manifestations of systemic vasculitis,in it m discussing about WEGNER,S GRANULOMATOSIS, churg-strauss syndrome and MPA
New technology called Electromagnetic Navigation Bronchoscopy® (ENB) that uses virtual bronchoscopy and real time 3-dimensional CT images that enable me to localize these peripheral lung nodules for diagnosis and treatment. This outpatient procedure is minimally invasive and therefore has a small risk of pneumothorax (2-3%) and its published diagnostic yield rates range from 67% - 86%
This presentation is about pulmonary manifestations of systemic vasculitis,in it m discussing about WEGNER,S GRANULOMATOSIS, churg-strauss syndrome and MPA
New technology called Electromagnetic Navigation Bronchoscopy® (ENB) that uses virtual bronchoscopy and real time 3-dimensional CT images that enable me to localize these peripheral lung nodules for diagnosis and treatment. This outpatient procedure is minimally invasive and therefore has a small risk of pneumothorax (2-3%) and its published diagnostic yield rates range from 67% - 86%
Scores in Pulmonary Medicine & Critical Care by Dr. Jebin AbrahamJebin Abraham
Scores used in pulmonary and critical care medicine, ICU and emergency medical wards etc. It includes glasgow coma scale,Dyspnea scoring,Clubbing, Anemia, edema, shock,SGRQ, CAT Score, ABCD assessment of COPD, BODE index, asthma,abpa,byssinosis,cURB-65,SOAR, PSI,CPIS, APACHE,WELLS score, YEARS sore,GENEVA score, PIOPED criteria, LIghts criteria,OSA, Berlin questionnaire, Lung cancer, Cancer staging, ICU and critical care, mallampati score, Revised trauma score, SOFA score, SAPS, Scadding staging of sarcoidosis etc. Scores are adapted from various internet and other sources and combined by Dr. Jebin Abraham
Scores in Pulmonary Medicine & Critical Care by Dr. Jebin AbrahamJebin Abraham
Scores used in pulmonary and critical care medicine, ICU and emergency medical wards etc. It includes glasgow coma scale,Dyspnea scoring,Clubbing, Anemia, edema, shock,SGRQ, CAT Score, ABCD assessment of COPD, BODE index, asthma,abpa,byssinosis,cURB-65,SOAR, PSI,CPIS, APACHE,WELLS score, YEARS sore,GENEVA score, PIOPED criteria, LIghts criteria,OSA, Berlin questionnaire, Lung cancer, Cancer staging, ICU and critical care, mallampati score, Revised trauma score, SOFA score, SAPS, Scadding staging of sarcoidosis etc. Scores are adapted from various internet and other sources and combined by Dr. Jebin Abraham
Presentation for Research Methodology
Please download the file and view the presentation.
Notes for each of the slides are present in the notes section
(Images used for representational purposes only)
In this lecture you will learn about the importance of research questions, how they related to research problems, the properties of good research questions, and the differences between quantitative and qualitative research questions.
Diagnosis of Pulmonary Embolism is often difficult. This presentation highlights step-wise and practical approach to the diagnosis of PE in short and precise fashion.
Percutaneous Balloon Mitral Valvuloplasty (PBMV) is a procedure to dilated the mitral valve in the setting of rheumatic mitral valve stenosis. A catheter is inserted into the femoral vein, advanced to the right atrium and across the interatrial septum. Then the mitral valve is crossed with a balloon and it is inflated to relieve the fusion of the mitral valve commissures effectively acting to increase the mitral valve area and reduce the degree of mitral stenosis. Mitral regurgitation is a potential complication and thus PBMV is contraindicated if moderate or severe regurgitation is present. The Wilkins score examines mitral valve morphology and is determined via echocardiography to assess the likelihood of using PBMV based on certain echocardiographic criteria.
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journeygreendigital
Tom Selleck, an enduring figure in Hollywood. has captivated audiences for decades with his rugged charm, iconic moustache. and memorable roles in television and film. From his breakout role as Thomas Magnum in Magnum P.I. to his current portrayal of Frank Reagan in Blue Bloods. Selleck's career has spanned over 50 years. But beyond his professional achievements. fans have often been curious about Tom Selleck Health. especially as he has aged in the public eye.
Follow us on: Pinterest
Introduction
Many have been interested in Tom Selleck health. not only because of his enduring presence on screen but also because of the challenges. and lifestyle choices he has faced and made over the years. This article delves into the various aspects of Tom Selleck health. exploring his fitness regimen, diet, mental health. and the challenges he has encountered as he ages. We'll look at how he maintains his well-being. the health issues he has faced, and his approach to ageing .
Early Life and Career
Childhood and Athletic Beginnings
Tom Selleck was born on January 29, 1945, in Detroit, Michigan, and grew up in Sherman Oaks, California. From an early age, he was involved in sports, particularly basketball. which played a significant role in his physical development. His athletic pursuits continued into college. where he attended the University of Southern California (USC) on a basketball scholarship. This early involvement in sports laid a strong foundation for his physical health and disciplined lifestyle.
Transition to Acting
Selleck's transition from an athlete to an actor came with its physical demands. His first significant role in "Magnum P.I." required him to perform various stunts and maintain a fit appearance. This role, which he played from 1980 to 1988. necessitated a rigorous fitness routine to meet the show's demands. setting the stage for his long-term commitment to health and wellness.
Fitness Regimen
Workout Routine
Tom Selleck health and fitness regimen has evolved. adapting to his changing roles and age. During his "Magnum, P.I." days. Selleck's workouts were intense and focused on building and maintaining muscle mass. His routine included weightlifting, cardiovascular exercises. and specific training for the stunts he performed on the show.
Selleck adjusted his fitness routine as he aged to suit his body's needs. Today, his workouts focus on maintaining flexibility, strength, and cardiovascular health. He incorporates low-impact exercises such as swimming, walking, and light weightlifting. This balanced approach helps him stay fit without putting undue strain on his joints and muscles.
Importance of Flexibility and Mobility
In recent years, Selleck has emphasized the importance of flexibility and mobility in his fitness regimen. Understanding the natural decline in muscle mass and joint flexibility with age. he includes stretching and yoga in his routine. These practices help prevent injuries, improve posture, and maintain mobilit
- Video recording of this lecture in English language: https://youtu.be/lK81BzxMqdo
- Video recording of this lecture in Arabic language: https://youtu.be/Ve4P0COk9OI
- Link to download the book free: https://nephrotube.blogspot.com/p/nephrotube-nephrology-books.html
- Link to NephroTube website: www.NephroTube.com
- Link to NephroTube social media accounts: https://nephrotube.blogspot.com/p/join-nephrotube-on-social-media.html
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdfAnujkumaranit
Artificial intelligence (AI) refers to the simulation of human intelligence processes by machines, especially computer systems. It encompasses tasks such as learning, reasoning, problem-solving, perception, and language understanding. AI technologies are revolutionizing various fields, from healthcare to finance, by enabling machines to perform tasks that typically require human intelligence.
NVBDCP.pptx Nation vector borne disease control programSapna Thakur
NVBDCP was launched in 2003-2004 . Vector-Borne Disease: Disease that results from an infection transmitted to humans and other animals by blood-feeding arthropods, such as mosquitoes, ticks, and fleas. Examples of vector-borne diseases include Dengue fever, West Nile Virus, Lyme disease, and malaria.
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?bkling
Are you curious about what’s new in cervical cancer research or unsure what the findings mean? Join Dr. Emily Ko, a gynecologic oncologist at Penn Medicine, to learn about the latest updates from the Society of Gynecologic Oncology (SGO) 2024 Annual Meeting on Women’s Cancer. Dr. Ko will discuss what the research presented at the conference means for you and answer your questions about the new developments.
Recomendações da OMS sobre cuidados maternos e neonatais para uma experiência pós-natal positiva.
Em consonância com os ODS – Objetivos do Desenvolvimento Sustentável e a Estratégia Global para a Saúde das Mulheres, Crianças e Adolescentes, e aplicando uma abordagem baseada nos direitos humanos, os esforços de cuidados pós-natais devem expandir-se para além da cobertura e da simples sobrevivência, de modo a incluir cuidados de qualidade.
Estas diretrizes visam melhorar a qualidade dos cuidados pós-natais essenciais e de rotina prestados às mulheres e aos recém-nascidos, com o objetivo final de melhorar a saúde e o bem-estar materno e neonatal.
Uma “experiência pós-natal positiva” é um resultado importante para todas as mulheres que dão à luz e para os seus recém-nascidos, estabelecendo as bases para a melhoria da saúde e do bem-estar a curto e longo prazo. Uma experiência pós-natal positiva é definida como aquela em que as mulheres, pessoas que gestam, os recém-nascidos, os casais, os pais, os cuidadores e as famílias recebem informação consistente, garantia e apoio de profissionais de saúde motivados; e onde um sistema de saúde flexível e com recursos reconheça as necessidades das mulheres e dos bebês e respeite o seu contexto cultural.
Estas diretrizes consolidadas apresentam algumas recomendações novas e já bem fundamentadas sobre cuidados pós-natais de rotina para mulheres e neonatos que recebem cuidados no pós-parto em unidades de saúde ou na comunidade, independentemente dos recursos disponíveis.
É fornecido um conjunto abrangente de recomendações para cuidados durante o período puerperal, com ênfase nos cuidados essenciais que todas as mulheres e recém-nascidos devem receber, e com a devida atenção à qualidade dos cuidados; isto é, a entrega e a experiência do cuidado recebido. Estas diretrizes atualizam e ampliam as recomendações da OMS de 2014 sobre cuidados pós-natais da mãe e do recém-nascido e complementam as atuais diretrizes da OMS sobre a gestão de complicações pós-natais.
O estabelecimento da amamentação e o manejo das principais intercorrências é contemplada.
Recomendamos muito.
Vamos discutir essas recomendações no nosso curso de pós-graduação em Aleitamento no Instituto Ciclos.
Esta publicação só está disponível em inglês até o momento.
Prof. Marcus Renato de Carvalho
www.agostodourado.com
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...GL Anaacs
Contact us if you are interested:
Email / Skype : kefaya1771@gmail.com
Threema: PXHY5PDH
New BATCH Ku !!! MUCH IN DEMAND FAST SALE EVERY BATCH HAPPY GOOD EFFECT BIG BATCH !
Contact me on Threema or skype to start big business!!
Hot-sale products:
NEW HOT EUTYLONE WHITE CRYSTAL!!
5cl-adba precursor (semi finished )
5cl-adba raw materials
ADBB precursor (semi finished )
ADBB raw materials
APVP powder
5fadb/4f-adb
Jwh018 / Jwh210
Eutylone crystal
Protonitazene (hydrochloride) CAS: 119276-01-6
Flubrotizolam CAS: 57801-95-3
Metonitazene CAS: 14680-51-4
Payment terms: Western Union,MoneyGram,Bitcoin or USDT.
Deliver Time: Usually 7-15days
Shipping method: FedEx, TNT, DHL,UPS etc.Our deliveries are 100% safe, fast, reliable and discreet.
Samples will be sent for your evaluation!If you are interested in, please contact me, let's talk details.
We specializes in exporting high quality Research chemical, medical intermediate, Pharmaceutical chemicals and so on. Products are exported to USA, Canada, France, Korea, Japan,Russia, Southeast Asia and other countries.
Ethanol (CH3CH2OH), or beverage alcohol, is a two-carbon alcohol
that is rapidly distributed in the body and brain. Ethanol alters many
neurochemical systems and has rewarding and addictive properties. It
is the oldest recreational drug and likely contributes to more morbidity,
mortality, and public health costs than all illicit drugs combined. The
5th edition of the Diagnostic and Statistical Manual of Mental Disorders
(DSM-5) integrates alcohol abuse and alcohol dependence into a single
disorder called alcohol use disorder (AUD), with mild, moderate,
and severe subclassifications (American Psychiatric Association, 2013).
In the DSM-5, all types of substance abuse and dependence have been
combined into a single substance use disorder (SUD) on a continuum
from mild to severe. A diagnosis of AUD requires that at least two of
the 11 DSM-5 behaviors be present within a 12-month period (mild
AUD: 2–3 criteria; moderate AUD: 4–5 criteria; severe AUD: 6–11 criteria).
The four main behavioral effects of AUD are impaired control over
drinking, negative social consequences, risky use, and altered physiological
effects (tolerance, withdrawal). This chapter presents an overview
of the prevalence and harmful consequences of AUD in the U.S.,
the systemic nature of the disease, neurocircuitry and stages of AUD,
comorbidities, fetal alcohol spectrum disorders, genetic risk factors, and
pharmacotherapies for AUD.
Explore natural remedies for syphilis treatment in Singapore. Discover alternative therapies, herbal remedies, and lifestyle changes that may complement conventional treatments. Learn about holistic approaches to managing syphilis symptoms and supporting overall health.
Title: Sense of Smell
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the primary categories of smells and the concept of odor blindness.
Explain the structure and location of the olfactory membrane and mucosa, including the types and roles of cells involved in olfaction.
Describe the pathway and mechanisms of olfactory signal transmission from the olfactory receptors to the brain.
Illustrate the biochemical cascade triggered by odorant binding to olfactory receptors, including the role of G-proteins and second messengers in generating an action potential.
Identify different types of olfactory disorders such as anosmia, hyposmia, hyperosmia, and dysosmia, including their potential causes.
Key Topics:
Olfactory Genes:
3% of the human genome accounts for olfactory genes.
400 genes for odorant receptors.
Olfactory Membrane:
Located in the superior part of the nasal cavity.
Medially: Folds downward along the superior septum.
Laterally: Folds over the superior turbinate and upper surface of the middle turbinate.
Total surface area: 5-10 square centimeters.
Olfactory Mucosa:
Olfactory Cells: Bipolar nerve cells derived from the CNS (100 million), with 4-25 olfactory cilia per cell.
Sustentacular Cells: Produce mucus and maintain ionic and molecular environment.
Basal Cells: Replace worn-out olfactory cells with an average lifespan of 1-2 months.
Bowman’s Gland: Secretes mucus.
Stimulation of Olfactory Cells:
Odorant dissolves in mucus and attaches to receptors on olfactory cilia.
Involves a cascade effect through G-proteins and second messengers, leading to depolarization and action potential generation in the olfactory nerve.
Quality of a Good Odorant:
Small (3-20 Carbon atoms), volatile, water-soluble, and lipid-soluble.
Facilitated by odorant-binding proteins in mucus.
Membrane Potential and Action Potential:
Resting membrane potential: -55mV.
Action potential frequency in the olfactory nerve increases with odorant strength.
Adaptation Towards the Sense of Smell:
Rapid adaptation within the first second, with further slow adaptation.
Psychological adaptation greater than receptor adaptation, involving feedback inhibition from the central nervous system.
Primary Sensations of Smell:
Camphoraceous, Musky, Floral, Pepperminty, Ethereal, Pungent, Putrid.
Odor Detection Threshold:
Examples: Hydrogen sulfide (0.0005 ppm), Methyl-mercaptan (0.002 ppm).
Some toxic substances are odorless at lethal concentrations.
Characteristics of Smell:
Odor blindness for single substances due to lack of appropriate receptor protein.
Behavioral and emotional influences of smell.
Transmission of Olfactory Signals:
From olfactory cells to glomeruli in the olfactory bulb, involving lateral inhibition.
Primitive, less old, and new olfactory systems with different path
3. CASE PRESENTATION
PAVM REVIEW 3
• Male patient named Gamal Hamed Wahba, 35 year old , from
Domietta, married and has 3 offsprings ,working painting worker
previously butcher, and he is current smoker.
• The condition started 2 years ago by recurrent attacks of
coughing of frank blood . More than one cup per day .
• No other chest complaints .
4. CASE PRESENTATION - cont
PAVM REVIEW 4
• Gamal has hx of Pulmonary Tuberculosis 5 years ago and
received anti-tuberculous ttt for 6m .
• No other relevant medical diseases .
• Gamal has past hx of stabbing chest trauma on the left side 13 y
ago.
5. CASE PRESENTATION - cont
PAVM REVIEW 5
• Gamal appeared generally well . He had no positive signs in
general examination apart from finger clubbing .
• O2sat on room air : 88% .
• Local Examination : NAD .
• All laboratory parameters are within normal regarding to CBC ,
LFT , S.Cr , INR , ESR , Virology markers .
21. INTRODUCTION
PAVM REVIEW 21
• Pulmonary arteriovenous malformations (PAVMs) are low-
resistance, high-flow abnormal vascular structures that most
often connect a pulmonary artery to a pulmonary vein .
• bypassing the normal pulmonary capillary bed and resulting in an
intrapulmonary right to-left shunt.
• Physiologic consequences depend on the degree of right-to-left
shunt and include hypoxemia, dyspnea, and cyanosis.
22. INTRODUCTION -cont
PAVM REVIEW 22
• The pulmonary capillary bed is
a sieve measuring 8 to 10 um in
diameter.
• PAVMs predispose to
complications of paradoxical
systemic embolization, including
stroke and brain abscess.
• Anti-biotics ?!!
23. INTRODUCTION -cont
PAVM REVIEW 23
• PAVMs usually are hereditary, with most associated with
hereditary hemorrhagic telangiectasia (HHT) .
• Hereditary PAVMs tend to increase in size over time, usually
expanding and becoming more evident in the second and third
decades of life.
25. BACKGROUNG
PAVM REVIEW 25
• HHT, known also as Osler-Weber-Rendu syndrome.
• Approximately 90% of adults with HHT have epistaxis;
however, up to 50% of patients with HHT have PAVMs .
• Conversely, of patients with PAVM, it is likely that as many as
90% will prove to have HHT.
30. EPIDEMIOLOGY
PAVM REVIEW 30
• the approximate incidence of PAVM has been described to be
two to three per 100,000.
• male-to-female ratio of approximately 1:1.5 to 1.8 .
• most are diagnosed in the first 3 decades of life.
32. PATHOPHYSIOLOGY
PAVM REVIEW 32
• PAVMs may be single or multiple, unilateral or bilateral, and simple or
complex.
• Most solitary PAVMs are seen in the lower lobes, with the left lower
lobe being the most common location followed by right lower lobe.
• The majority of multiple PAVMs are also confined to the lower lobes.
• Simple PAVMs receive blood through a single artery, and complex
PAVMs receive blood through two or more arteries.
33. PATHOPHYSIOLOGY- cont
PAVM REVIEW 33
• The afferent supply is most often a branch of the pulmonary
artery; however, in rare cases, it can derive from the systemic
circulation, including the bronchial and intercostal arteries.
• The efferent limb of the PAVM often communicates with
branches of the pulmonary vein, although direct communication
with the inferior vena cava have been described.
34. PATHOPHYSIOLOGY- cont
PAVM REVIEW 34
• The abnormal segment between the pulmonary artery and the
pulmonary vein is fragile and may rupture and bleed as the
PAVM size increases and manifests as hemoptysis or
hemothorax.
• Right-to-left shunt that causes hypoxemia and paradoxical
emboli are the main complications of PAVM.
• In healthy individuals, shunt is usually ,2% of the cardiac output.
35. PATHOPHYSIOLOGY- cont
PAVM REVIEW 35
• The degree of shunt determines the severity of hypoxemia, with
severe symptoms present when the shunt exceeds 20% of the
cardiac output.
• The shunt present in PAVM causes hypoxemia because blood
flows directly from the pulmonary artery to the pulmonary vein,
bypassing the capillary-alveolar barrier with no effective gas
exchange.
37. ETIOLOGY
PAVM REVIEW 37
• Most PAVMs are hereditary, with about 90% occurring in patients with HHT .
• The majority of the non-HHT-related PAVMs are idiopathic.
• Other causes include :-
- infections, such as schistosomiasis and actinomycosis , tuberculosis .
- trauma , post-thoracic surgery.
• PAVMs can also occur secondary to hepatopulmonary syndrome (HPS) .
40. CLINICAL MANIFESTATIONS
PAVM REVIEW 40
• Signs and symptoms of patients with PAVM vary depending on
the size, number, and flow through the PAVM.
• In general, a single PAVM of less than 2 cm in size does not
usually result in symptoms.
• Patients may be completely asymptomatic or experience
dyspnea on exertion.
41. CLINICAL MANIFESTATIONS - cont
PAVM REVIEW 41
• Hypoxemia at rest or with exercise may be present, especially
in the presence of a significant intrapulmonary shunt.
• Orthodeoxia (worsening hypoxemia when upright) and
platypnea (worsening dyspnea when upright) may be evident
because 80% of PAVMs are in the lower lung fields.
• The classic triad of dyspnea, cyanosis, and clubbing is seen in a
minority of patients.
44. COMPLICATIONS
PAVM REVIEW 44
• Neurological
x Cerebral abscess (25%)
x Cerebrovascular strokes (20%)
x Transient ischaemic attacks (55%)
x Migraine (40%)
x Seizures (8%)
• Cardiovascular
x Pulmonary hypertension
x High output cardiac failure
x Paradoxical embolism
45. COMPLICATIONS - cont
PAVM REVIEW 45
• Pulmonary
x Haemoptysis
x Haemothorax (2%)
• Haematological
xPolycythaemia
• Surgical resection, with its morbidity and peri-operative
complications .
47. DIAGNOSTIC TESTING - CXR
PAVM REVIEW 47
• Classically appears as a well-defined round or oval sharply
defined nodule or mass .
• routine screening with chest roentgenogram insensitive.
48. DIAGNOSTIC TESTING – TTCE
(bubble echocardiogram)
PAVM REVIEW 48
• Higher sensitivity and safety is
seen with contrast
echocardiography.
• TTCE is a safe screening test for
intrapulmonary shunt, with a
sensitivity of 100% and a
specificity ranging from 67% to
90%.
49. DIAGNOSTIC TESTING – TTCE
(bubble echocardiogram)
PAVM REVIEW 49
• TTCE was performed by placing an IV line to which two 10-mL
syringes were connected, one filled with an 8-mL physiologic
saline solution and the other with 1 mL of air. Subsequently, 1
mL of blood was drawn in the air-filled syringe and mixed with
the saline-filled syringe by reverse flushing between both
syringes, creating agitated saline (microbubbles).
• The patient was positioned in the left lateral decubitus position,
and 10 mL of agitated saline was injected while projecting the
four-chamber apical view without a Valsalva maneuver.
51. DIAGNOSTIC TESTING – TTCE
(bubble echocardiogram)
PAVM REVIEW 51
• Pitfalls of TTCE : -
- very sensitive , it may be positive even if no PAVM detected
in CT .
- it remains positive after treatment in up to 90% of patients .
• Such results may correspond :-
- false positive test result .
- diffuse and or microscopic PAVM .
53. DIAGNOSTIC TESTING – CCT scan
PAVM REVIEW 53
• CCT scan is not part of the PAVM screening process.
• Used in further evaluation of patients with a high suspicion of
PAVM. In the setting of a TTCE suggestive of intrapulmonary
shunt.
• Maximum intensity projection reconstruction (MIPR) showing
one or more enlarged arteries feeding a serpiginous mass or
nodule and one or more draining veins is diagnostic .
55. DIAGNOSTIC TESTING – pulmonary angiography
PAVM REVIEW 55
• Pulmonary angiography generally is no longer necessary as a
diagnostic procedure alone.
• It is reserved for therapeutic purposes after a diagnosis has
been established.
• It remains the gold standard for inconclusive cases.
56. DIAGNOSTIC TESTING – MRI
PAVM REVIEW 56
• Noninvasive methods available, contrast-enhanced magnetic
resonance angiography (CE-MRA).
• Provide precise information on the number, location, and
complexity of PAVMs.
• The possibility of detecting small PAVMs.
• Avoid complications of catheter angiography .
58. DIAGNOSTIC TESTING – MRI
PAVM REVIEW 58
• The main disadvantages are :-
- expense.
-potential side effects of gadolinium-based contrast in
patients with renal disease .
- time of the procedure .
- limited availability in some centers .
-specialized nature of the test.
59. DIAGNOSTIC TESTING – Right-to-Left
Shunt Assessment
PAVM REVIEW 59
• Radionuclide imaging with 99m Tc-labeled macro-aggregated
albumin lung-brain perfusion scanning .
• The albumin microspheres have particle diameters of less than
20 um and are normally trapped in the capillaries of the lung.
• In the presence of PAVM, these particles pass through the lung,
and shunt fraction can be calculated by radionuclide scanning
over the brain, kidneys, or both.
60. DIAGNOSTIC TESTING – Right-to-Left
Shunt Assessment
PAVM REVIEW 60
• Radionuclide imaging is expensive, requires radiation, and is
not uniformly available at many facilities.
• radionuclide imaging does not differentiate between a cardiac or
pulmonary source of AVMs.
63. TREATMENT AND MANAGEMENT
PERCUTANEOUS TRANSCATHETER
EMBOLIZATION
PAVM REVIEW 63
• Percutaneous TCE is the gold standard for the treatment of
PAVM because it is effective in reducing the risk of paradoxical
embolism and other complications associated with PAVM.
• less invasive and easy to repeat .
• disadvantages include collateralization and revascularization
over time.
64. PERCUTANEOUS TRANSCATHETER
EMBOLIZATION
PAVM REVIEW 64
• Major indications for treatment are :-
- prevention of neurologic complications, including stroke and
cerebral abscess from paradoxical embolism.
- improvement in exercise tolerance .
- reduction in migraine prevalence .
- prevention of lung hemorrhage.
65. PERCUTANEOUS TRANSCATHETER
EMBOLIZATION
PAVM REVIEW 65
• During embolization, the supplying artery immediately preceding
the PAVM is the target to occlude the feeding vessel just
proximal to the aneurysmal sac .
• The deployed coils are designed to coil within the vessel lumen
and carry micro fibers that activate platelets to generate an
occluding platelet plug.
68. PERCUTANEOUS TRANSCATHETER
EMBOLIZATION
PAVM REVIEW 68
• Recanalization and collateralization of the post-embolization
PAVM can present in the range of 5% to 20%.
• No device appears to be superior in preventing recanalization.
• Study of 28 PAVMs showed that recanalization did not develop
between 6 and 40 months in patients treated with AVP and coils.
72. TREATMENT AND MANAGEMENT
SURGERY
PAVM REVIEW 72
• Surgical resection is rarely necessary because the
majority of PAVMs are amenable to TCE.
• Indications for surgery :-
- Complex of diffuse PAVMs not amenable to
embolotherapy.
73. TREATMENT AND MANAGEMENT
SURGERY
PAVM REVIEW 73
• Surgical techniques depend on the complexity of the PAVM and
include :-
-local excision.
-segmental resection.
- lobectomy.
- ligation.
- pneumonectomy.
- lung transplant.
75. FOLLOW-UP
PAVM REVIEW 75
• Recurrence of PAVM occurs after 15% of embolizations .
• Unpredictable .
• Results from :-
-recanalization of occluded PAVMs.
-collateralization from adjacent arteries.
- missed accessory pathways.
76. FOLLOW-UP - cont
PAVM REVIEW 76
• Long-term follow-up post-embolization is accomplished with
CCT scan performed 6 to 12 months after embolization and then
every 3 to 5 years.
78. SCREENING
PAVM REVIEW 78
• All patients with hereditary haemorrhagic telangiectasia should
undergo routine screening .
• contrast echocardiography is very sensitive .
• contrast echocardiography can be too sensitive by detecting
clinically insignificant micro-vascular shunts .
80. PAVM AND PREGNANCY
PAVM REVIEW 80
• PAVMs often increase in size and number during pregnancy .
• Mostly during 2nd and 3rd trimester due to hormonal and
hemodynamic factors .
• Patients with known hx of PAVM or HHT should have close
monitoring during pregnancy.
• After 16 week of gestation , embolotherapy can be safe and
effictive.
82. HOME TAKEAWAYS
PAVM REVIEW 82
• PAVMs are abnormal vascular structures that most often
connect a pulmonary artery to a pulmonary vein, bypassing the
normal pulmonary capillary bed and resulting in an
intrapulmonary right-to-left shunt.
• The main complications of PAVM result from intrapulmonary
shunt and include stroke, brain abscess, and hypoxemia.
83. HOME TAKEAWAYS - cont
PAVM REVIEW 83
• The most common cause of PAVM is HHT.
• Embolization with the use of TCE is the treatment of choice and
is safe and effective in experienced hands.
• Collateralization and recanalization may occur, so lifelong
follow-up is important.
84. HOME TAKEAWAYS - cont
PAVM REVIEW 84
• Patients with PAVM should receive antibiotic prophylaxis for
procedures likely to induce bacteraemia.
• Air-filters should be placed in IV access site prior to any
procedure .
• Family members of patients with PAVMs should be screened.
• No diving .